Eledon Pharmaceuticals
ELDN
19 hedge funds and large institutions have $60.6M invested in Eledon Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 8 closing their positions.
2,077% more capital invested
Capital invested by funds: $2.78M → $60.6M (+$57.8M)
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
0.65% more ownership
Funds ownership: 2.1% → 2.75% (+0.65%)
5% less funds holding
Funds holding: 20 → 19 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$947K |
| 2 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$596K |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$356K |
| 4 |
Renaissance Technologies
New York
|
+$67.2K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$33.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$42K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$25K |
| 3 |
Jane Street
New York
|
-$19K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$15K |
| 5 |
BCM
Bayesian Capital Management
Brooklyn,
New York
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| – | +$10 | +1 | +25% |
|
ELDN Hedge Fund Activity: Q3 2020 in Review
19 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Eledon Pharmaceuticals (ELDN) for Q3 2020, worth a combined $60.6M — up 2,077% from $2.78M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ELDN and 7 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 5 added.
The largest buyer was BVF Inc, adding an estimated $947K. The largest seller was Virtu Financial, exiting entirely with an estimated $42K sold.
- 19 institutional investors held Eledon Pharmaceuticals (ELDN) as of Q3 2020, down from 20 in Q2 2020.
- Funds reported $60.6M of Eledon Pharmaceuticals stock for Q3 2020, up 2,077% quarter-over-quarter.
- 7 funds opened new Eledon Pharmaceuticals positions in Q3 2020 and 8 closed out, a net change of -1 holder.
- The largest Eledon Pharmaceuticals buyer in Q3 2020 was BVF Inc, an estimated $947K added.
- The largest Eledon Pharmaceuticals seller in Q3 2020 was Virtu Financial, an estimated $42K sold.
Based on aggregated 13F filings for Q3 2020.